Moreover, DEX treatment (0.5 g/kg/h, pumping injection, before induction of anesthesia to the end of surgery) has been reported to reduce cardiac troponin I and MDA levels and to decrease the incidence of arrhythmias in patients undergoing cardiac valve replacement [234, 235]
Commun Biol 5 , 326 (2022)
Methods Ethics declarations All the animal experiments were performed following the Guide for Care and Use of Laboratory Animals, approved by the Animal Experimentation Ethics Committee of China Pharmaceutical University (2022-10-017)
Yes, some GLP-1 receptor agonists, such as liraglutide and semaglutide, have been shown to reduce the risk of major cardiovascular events in people with type 2 diabetes and cardiovascular disease
Lack of sleep has always been an issue
Plaintiffs in this MDL allege that GLP-1 drugs increased the risk of NAION and that manufacturers failed to adequately warn patients and health care providers about this potential danger